Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion

Purposes. The study introduced the concept of “consecutive macular edema” and evaluated the validity of visual outcome in macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Methods. Patients were categorized into the gainer group and the nongainer group according to the final visu...

Full description

Saved in:
Bibliographic Details
Main Authors: Sung Uk Baek, Soon Il Kwon, In Won Park, Kyung Jun Choi
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2014/439483
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850231876503994368
author Sung Uk Baek
Soon Il Kwon
In Won Park
Kyung Jun Choi
author_facet Sung Uk Baek
Soon Il Kwon
In Won Park
Kyung Jun Choi
author_sort Sung Uk Baek
collection DOAJ
description Purposes. The study introduced the concept of “consecutive macular edema” and evaluated the validity of visual outcome in macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Methods. Patients were categorized into the gainer group and the nongainer group according to the final visual acuity. We analyzed clinical characteristics involving total and consecutive duration of ME between the two groups. Results. Among the total 71 eyes of 71 patients, intravitreal bevacizumab injection (26 patients), triamcinolone (21), and natural course (33) were enrolled. The consecutive duration of ME was shorter in the gainer group than in the nongainer group (3.33 ± 1.50 and 5.24 ± 2.39 months; P=0.000). After exclusion of macular ischemia, consecutive duration of ME in gainer group was also significantly shorter than in nongainer group (3.62 ± 1.60 and 6.11 ± 4.20 months; P=0.010). Conclusions. The duration of ME in the nongainer group was longer than in the gainer group. In particular, the consecutive duration was an important factor in determining the final visual outcome. Clinical Trial Registration. Approval by Hallym University Sacred Heart Hospital Institutional Review Board/Ethics Committee was obtained for this retrospective study.
format Article
id doaj-art-08ed914cf2ff488996b33b3a468bbf90
institution OA Journals
issn 2090-004X
2090-0058
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-08ed914cf2ff488996b33b3a468bbf902025-08-20T02:03:23ZengWileyJournal of Ophthalmology2090-004X2090-00582014-01-01201410.1155/2014/439483439483Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein OcclusionSung Uk Baek0Soon Il Kwon1In Won Park2Kyung Jun Choi3Department of Ophthalmology, Hallym University Sacred Heart Hospital, No. 896 Pyeongchon-dong, Anyang, Gyeonggi-do 431-070, Republic of KoreaDepartment of Ophthalmology, Hallym University Sacred Heart Hospital, No. 896 Pyeongchon-dong, Anyang, Gyeonggi-do 431-070, Republic of KoreaDepartment of Ophthalmology, Hallym University Sacred Heart Hospital, No. 896 Pyeongchon-dong, Anyang, Gyeonggi-do 431-070, Republic of KoreaDepartment of Ophthalmology, Hallym University Sacred Heart Hospital, No. 896 Pyeongchon-dong, Anyang, Gyeonggi-do 431-070, Republic of KoreaPurposes. The study introduced the concept of “consecutive macular edema” and evaluated the validity of visual outcome in macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Methods. Patients were categorized into the gainer group and the nongainer group according to the final visual acuity. We analyzed clinical characteristics involving total and consecutive duration of ME between the two groups. Results. Among the total 71 eyes of 71 patients, intravitreal bevacizumab injection (26 patients), triamcinolone (21), and natural course (33) were enrolled. The consecutive duration of ME was shorter in the gainer group than in the nongainer group (3.33 ± 1.50 and 5.24 ± 2.39 months; P=0.000). After exclusion of macular ischemia, consecutive duration of ME in gainer group was also significantly shorter than in nongainer group (3.62 ± 1.60 and 6.11 ± 4.20 months; P=0.010). Conclusions. The duration of ME in the nongainer group was longer than in the gainer group. In particular, the consecutive duration was an important factor in determining the final visual outcome. Clinical Trial Registration. Approval by Hallym University Sacred Heart Hospital Institutional Review Board/Ethics Committee was obtained for this retrospective study.http://dx.doi.org/10.1155/2014/439483
spellingShingle Sung Uk Baek
Soon Il Kwon
In Won Park
Kyung Jun Choi
Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
Journal of Ophthalmology
title Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
title_full Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
title_fullStr Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
title_full_unstemmed Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
title_short Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
title_sort consecutive macular edema and visual outcome in branch retinal vein occlusion
url http://dx.doi.org/10.1155/2014/439483
work_keys_str_mv AT sungukbaek consecutivemacularedemaandvisualoutcomeinbranchretinalveinocclusion
AT soonilkwon consecutivemacularedemaandvisualoutcomeinbranchretinalveinocclusion
AT inwonpark consecutivemacularedemaandvisualoutcomeinbranchretinalveinocclusion
AT kyungjunchoi consecutivemacularedemaandvisualoutcomeinbranchretinalveinocclusion